Patient Centered Treatment for Substance Use Disorder in Primary Care – Recorded (On Demand) Training
Supporting patient-centered treatment of substance use disorder
This 12-module series provides practical guidance to care teams seeking to elevate the level of care provided to patients with substance use disorder (SUD). The odd-numbered modules in this series are focused on clinical best practices. The even-numbered modules in this series are focused on operational aspects of office-based addiction treatment (OBAT) and include interviews from practice, where practices who have implemented the materials covered in that module provide testimonials via brief interviews.
All 12 modules are available on-demand and can be completed in the order and at the pace that best fits the learning needs of the individual and their practice.
Participants of this module series will also have access to:
Session#1: Navigating Buprenorphine Prescribing for the PCP
This session is designed to outline a patient-centered approach to diagnosis of opioid use disorder and buprenorphine prescribing.
Session#2: Substance Use Disorder and Patient Identification
This session is designed to guide the participant through implementation of screening and patient identification procedures for substance use disorder.
Session#3: Buprenorphine Medical Management: Monitoring the Patient
This session is designed to outline best practices associated with drug testing for monitoring patients with substance use disorder.
Session#4: OBAT Eligibility, Intake and Assessment
This session is designed to guide the participant through developing in-office procedures for screening and intake into an OBAT program and the initial provider assessment.
Session#5: Challenging Clinical Scenarios in MOUD: Early Refills and Lost or Stolen Medication
This session is designed to outline best practices for responding to challenging clinical scenarios, including requests for early refills and patient-reported lost of stolen medications.
Session#6: Patient Support for Induction and Maintenance
This session is designed to provide guidance on implementation of office-based induction and maintenance of buprenorphine using the OBAT model.
Session#7: Complex Cases in Buprenorphine Treatment Part 1
This session is designed to provide the opportunity for review and consideration of specific patient cases from practice, including those related to co-occurring alcohol use disorder.
Session#8: Operationalizing Team Meetings, Systematic Case Review & Documentation
This session is designed to review best practices related to interprofessional communication, team meetings, and documentation.
Session#9: Complex Cases in Buprenorphine Treatment Part 2
This session is designed to provide the opportunity for review and consideration of specific patient cases from practice, including those related to substance use disorder in pregnancy.
Session#10: Team Roles and Responsibilities
This session is designed to describe roles and responsibilities of team members engaged in OBAT.
Session#11: Pain and Addiction
This session is designed to review approaches to managing co-occurring pain and substance use disorder, including application to individual patient cases.
Session#12: Supporting the Patient Beyond Buprenorphine
This session is designed to describe key opportunities to support a patient with substance use disorder, including care coordination, services and interventions, and problem solving related to special populations and complex situations.
This series is intended for providers, nurses, social workers, medical assistants, community health works, and other care team members who are seeking to expand their knowledge and skills.
FacultyEdward Jouney, D.O., M.S.
Dr. Jouney is an addiction psychiatrist and forensic psychiatric fellow at the Center for Forensic Psychiatry at Michigan Medicine in the Department of Psychiatry. He is a consulting psychiatrist at the UM High-Risk OB Clinic and has successfully trained in Addiction Psychiatry at the University of Michigan. Dr. Jouney received his D.O. degree at Michigan State University, College of Osteopathic Medicine, and completed residency training in Psychiatry at the University of Michigan. He is a member of the American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry. Dr. Jouney serves on the University of Michigan Health System Controlled Substance Quality Improvement Committee.
Claire Nolan received her Doctor of Pharmacy degree from the Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences in Detroit, MI. Dr. Nolan has experience in the specialty, ambulatory, and community pharmacy practice settings. She has focused her career on continuous quality improvement, program development, and education.
Robin Schreur is a trainer for the Michigan Center for Clinical Systems Improvement (Mi-CCSI). She served as the Clinical Lead Care Manager in Ambulatory Care at Spectrum Health from 2012 until 2020. Her aim is to instill the importance of patient-centered care across the continuum of care. Robin has worked in a variety of settings including insurance-based and primary care practices, and as a behavioral health nurse at an inpatient facility. She has extensive experience in training and onboarding hundreds of clinicians in care management roles and motivational interviewing.
Cost is per session and may be paid by credit card through PayPal.
CONTINUING EDUCATION CREDITS
Providers & Nurses
The AAFP has reviewed Patient Centered Treatment for Substance Use Disorder in Primary Care, and deemed it acceptable for AAFP credit. Term of approval is from 09/01/2021 to 08/31/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following sessions:
- 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Navigating Buprenorphine Prescribing for the Primary Care Provider
- 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – SUD and patient identification
- 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Use of Buprenorphine: monitoring the patient
- 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Patient support for induction and maintenance
- 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Use of Buprenorphine in OUD Part 1
- 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – OBAT Eligibility: Intake and Assessment
- 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Use of Buprenorphine in OUD Part 2
- 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Operationalizing Team Meetings & Systematic Case Review
- 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Challenging Scenarios in MOUD
- 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Team roles and responsibilities: Office Operations to Support the Prescribing Provider
- 2.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Managing coexisting conditions: Pain and Addiction
- 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – Supporting the patient beyond Buprenorphine
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Note: Nurses can use CME credits toward re-licensure.
Michigan Board of Nursing Continuing Education Requirements Details
This course is approved by the NASW-Michigan Social Work Continuing Education Collaborative
Approval #: 081321-00
The course, when completed in full (participating in all sessions) is approved for a maximum of 18 contact hours.
Training Materials & Course Preparation
Course materials including the series toolkit and additional tools are found here.
If you have any questions, contact Amy at firstname.lastname@example.org